News
CRISPR-Cas9 presents new possibilities for Thalassemia treatment.
The autosomal recessive inherited blood disorder, b-thalassemia, is caused by reduced or absent synthesis of the beta chains of hemoglobin due to mutations within the
Visit us at EFI 2019
Just two weeks to go until this years European Immunogenetics and Histocompatibility Conference in Lisbon, Portugal. Will you be attending? Keep an eye out for
On our way to IVDR Compliance
We are very happy to announce that TÜV SÜD has verified the update of our quality management system to the latest revision – ISO13485:2016! This
Sweden’s best biotech workplace
Devyser is extremely proud to have been recognised as one of Sweden’s best workplaces (Small Organisations). Across all categories Devyser was the only nominated workplace
Devyser launches first NGS-based test for mixed chimerism
Swedish molecular diagnostics company Devyser, announced today at the 45th annual European Bone Marrow Transplantation (EBMT) meeting in Frankfurt, Germany, the release of a new
Simplify Gene Transcript Selection Using MANE Transcripts
For many genes, choosing the most optimal transcript for a specific analysis is a complex task. This is due to two main factors. Firstly, the
Genetic Data Sharing – Benefits and Burdens
Questions around genetic data sharing are coming into focus as our ability to sequence DNA improves, and digital privacy issues gain more awareness. Earlier this
Clinical trials highlights the importance of correct CFTR mutation detection in cystic fibrosis patients
Cystic Fibrosis is one of the most common genetic disorders. The disease is caused by mutations within the cystic fibrosis transmembrane conductance regulator gene (CFTR)
No Significant Reduction in Miscarriage Rates from NIPT Pre-Screening for Trisomy 21 as compared to invasive testing
A recent paper published by Malan et al in the Journal of the American Medical Association (JAMA) describes a clinical study conducted over two years